Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249
Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M et al (2000) Environmental and heritable factors in the causation of cancer–analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78–85
Article CAS PubMed Google Scholar
Chin L, Gray JW (2008) Translating insights from the cancer genome into clinical practice. Nature 452:553–563
Article CAS PubMed PubMed Central Google Scholar
Stratton MR (2011) Exploring the genomes of cancer cells: progress and promise. Science 331:1553–1558
Article CAS PubMed Google Scholar
Cardon LR, Bell JI (2001) Association study designs for complex diseases. Nat Rev Genet 2:91–99
Article CAS PubMed Google Scholar
Houlston RS, Cheadle J, Dobbins SE, Tenesa A, Jones AM, Howarth K et al (2010) Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33. Nat Genet 42:973–977
Article CAS PubMed PubMed Central Google Scholar
Balasubramanian SP, Brown NJ, Reed MW (2002) Role of genetic polymorphisms in tumour angiogenesis. Br J Cancer 87:1057–1065
Article CAS PubMed PubMed Central Google Scholar
Ferrara N, Gerber HP, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9:669–676
Article CAS PubMed Google Scholar
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674
Article CAS PubMed Google Scholar
Huang Z, Bao SD (2004) Roles of main pro- and anti-angiogenic factors in tumour angiogenesis. World J Gastroenterol 10:463–470
Article CAS PubMed PubMed Central Google Scholar
Dvorak HF (2000) VPF/VEGF and the angiogenic response. Semin Perinatol 24:75–78
Article CAS PubMed Google Scholar
Ferrara N (2004) Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25:581–611
Article CAS PubMed Google Scholar
Vincenti V, Cassano C, Rocchi M, Persico G (1996) Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation 93:1493–1495
Article CAS PubMed Google Scholar
Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, Pilger E (2000) A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 37:443–448
Article CAS PubMed Google Scholar
Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE (2000) Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 12:1232–1235
Article CAS PubMed Google Scholar
Stevens A, Soden J, Brenchley PE, Ralph S, Ray DW (2003) Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res 63:812–816
Mullaney JM, Mills RE, Pittard WS, Devine SE (2010) Small insertions and deletions (INDELs) in human genomes. Hum Mol Genet 19:R131–R136
Article CAS PubMed PubMed Central Google Scholar
Catalán A, Glaser-Schmitt A, Argyridou E, Duchen P, Parsch J (2016) An indel polymorphism in the MtnA 3’ untranslated region is associated with gene expression variation and local adaptation in drosophila melanogaster. PLoS Genet 12:e1005987
Article PubMed PubMed Central Google Scholar
Veerappa AM, Vishweswaraiah S, Lingaiah K, Murthy NM, Suresh RV, Belur K et al (2014) Insertion-deletions burden in copy number polymorphisms of the Tibetan population. Indian J Hum Genet 20:166–174
Article CAS PubMed PubMed Central Google Scholar
Yang B, Cross DF, Ollerenshaw M, Millward BA, Demaine AG (2003) Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mellitus. J Diabetes Complicat 17:1–6
Salvarani C, Boiardi L, Casali B, Olivieri I, Cantini F, Salvi F et al (2004) Vascular endothelial growth factor gene polymorphisms in Behçet’s disease. J Rheumatol 31:1785–1789
Guleria K, Kaur S, Mahajan D, Sambyal V, Sudan M, Uppal MS (2022) Impact of VEGFA promoter polymorphisms on esophageal cancer risk in North-West Indians: a case-control study. Genes Genomics 44:923–936
Article CAS PubMed Google Scholar
Wang Z, Li C, Li X, Shi J, Wu W (2023) Effect of vascular endothelial growth factor rs35569394 in esophageal cancer and response to chemotherapy. Biomol Biomed 23:271–276
CAS PubMed PubMed Central Google Scholar
Bayal AC, Sultana S, Nallari P, Ananthapur V (2021) Genetic polymorphisms of vascular endothelial growth factor (VEGF)-2549 I/D and+ 405G/C in the susceptibility to gastric cancer. Arch Clin Gastroenterol 7:1–6
He Y, Ni J, Chen S, Jiang Y, Jia S, Gao Y (2010) The vascular endothelial growth factor-2549 insertion/deletion polymorphism is not associated with susceptibility to hepatocellular carcinoma in Chinese. DNA Cell Biol 29:393–396
Article CAS PubMed Google Scholar
Mishra K, Behari A, Kapoor VK, Khan MS, Prakash S, Agrawal S (2013) Vascular endothelial growth factor single-nucleotide polymorphism in gallbladder cancer. J Gastroenterol Hepatol 28:1678–1685
Article CAS PubMed Google Scholar
Ungerbäck J, Elander N, Dimberg J, Söderkvist P (2009) Analysis of VEGF polymorphisms, tumor expression of VEGF mRNA and colorectal cancer susceptibility in a Swedish population. Mol Med Rep 2:435–439
Formica V, Palmirotta R, Del Monte G, Savonarola A, Ludovici G, De Marchis ML et al (2011) Predictive value of VEGF gene polymorphisms for metastatic colorectal cancer patients receiving first-line treatment including fluorouracil, irinotecan, and bevacizumab. Int J Colorectal Dis 26:143–151
Rollin J, Payancé A, Gouilleux-Gruart V, Boisdron-Celle M, Azzopardi N, Morel A et al (2015) Significant effect of VEGFA polymorphisms on the clinical outcome of metastatic colorectal cancer patients treated with FOLFIRI-cetuximab. Pharmacogenomics 16:2035–2043
Article CAS PubMed Google Scholar
Kong SY, Park JW, Lee JA, Park JE, Park KW, Hong EK et al (2007) Association between vascular endothelial growth factor gene polymorphisms and survival in hepatocellular carcinoma patients. Hepatology 46:446–455
Article CAS PubMed Google Scholar
Bruyère F, Hovens CM, Marson MN, d’Arcier BF, Costello AJ, Watier H et al (2010) VEGF polymorphisms are associated with an increasing risk of developing renal cell carcinoma. J Urol 184:1273–1278
Jaiswal PK, Tripathi N, Shukla A, Mittal RD (2013) Association of single nucleotide polymorphisms in vascular endothelial growth factor gene with bladder cancer risk. Med Oncol 30:509
留言 (0)